Fortis Healthcare Limited Files SEBI Disclosure for FY26 Bonds
Fortis Healthcare Limited filed its SEBI disclosure for FY26 bonds on April 10, 2026. The company detailed listing and credit rating information for its non-convertible securities. All interest payments were made on schedule, with no defaults reported.
This is a standard compliance filing related to existing debt instruments and does not represent a new strategic development or significant financial event for the company.
The announcement is a routine regulatory filing and does not contain any new financial performance data or strategic announcements that would positively or negatively impact the company's outlook.
Fortis Healthcare Limited has submitted its disclosure for the financial year ended March 31, 2026, in accordance with Chapter XIV of the SEBI Master Circular concerning the Centralized Database for corporate bonds and debentures. The filing, dated April 10, 2026, includes details on various debt instruments.
Specifically, the company provided listing details for three sets of non-convertible securities with ISINs INE061F07044 (Old)/INE061F08018 (New), INE061F07051 (Old)/INE061F08026 (New), and INE061F07069 (Old)/INE061F08034 (New). These instruments, each with a first issue size of ₹500 Crore, ₹500 Crore, and ₹550 Crore respectively, were allotted and listed on December 19, 2024, on the BSE.
The company also detailed its credit ratings, noting that CRISIL upgraded its rating to CRISIL AA+ with a stable outlook for these instruments on September 1, 2025, with verification on December 16, 2025. Earlier, the rating was CRISIL AA, upgraded on October 1, 2024. All interest payments for these bonds have been made on time, with the last payment on December 22, 2025, for the annual interest amounts of ₹406,398,027, ₹427,787,397, and ₹470,566,137 respectively. There have been no defaults or delays in servicing any debt security.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.